-

SHAREHOLDER ALERT: Robbins LLP Investigates Laboratory Corporation of America Holdings (LH) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Laboratory Corporation of America Holdings (NASDAQ: LH) to determine whether certain Labcorp officers and directors violated securities laws and breached fiduciary duties to shareholders. Labcorp is a clinical laboratory organization.

If you would like more information about our investigation of Laboratory Corporation of America Holdings' misconduct, click here.

Laboratory Corporation of America Holdings' (LH) Prenatal Tests May be Inaccurate

On January 1, 2022, an article from the New York Times called into question the accuracy of certain noninvasive prenatal tests, including that developed by Labcorp. The article alleges that positive results on tests are incorrect about 85% of the time. Patients who receive a positive result are supposed to pursue follow-up testing, which "can cost thousands of dollars, come with a small risk of miscarriage and can't be performed until later in pregnancy." The investigation highlights the statistical challenge of testing from things that are extremely rare. But, this isn't adequately explained to patients who were sold the tests. Companies that develop these tests use language like "highly accurate" and "total confidence," do not publish data on their tests' overall performance, or only stress data from tests that are more accurate.

On this news, Labcorp's stock fell over $16.00, or 5%, to close at $298.18 per share on January 3, 2022, injuring investors.

Laboratory Corporation of America Holdings (LH) shareholders have legal options. If you own shares of Labcorp, contact us for more information about your legal options.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Laboratory Corporation of America Holdings settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Babcock & Wilcox Enterprises, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Babcock & Wilcox Enterprises, Inc. (NYSE: BW) securities between November 5, 2025 and March 11, 2026. Babcock & Wilcox provides energy and emissions control solutions to industrial, electrical utility, municipal, and other customers in the U.S., Canada, the U.K., Indonesia, and the Philippines.For more information, submit a form, email...

Investor Notice: Robbins LLP Informs Investors of the United Homes Group, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired United Homes Group, Inc. (NASDAQ: UHG) securities between May 19, 2025 and February 22, 2026. United Homes is a residential home building company. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that United Homes Group, Inc. (UH...

Investor Notice: Robbins LLP Informs Investors of the Stellantis N.V. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Stellantis N.V. (NYSE: STLA) securities between February 26, 2025 and February 5, 2026. Stellantis is a global automobile designer, engineer, manufacturer, and distributor.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is Investigating Allegations that Stell...
Back to Newsroom